Physical Exercise Improves Peripheral BDNF Levels and Cognitive Functions in Mild Cognitive Impairment Elderly with Different BDNF Val66Met Genotypes

Carregando...
Imagem de Miniatura
Citações na Scopus
114
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
IOS PRESS
Autores
NASCIMENTO, Carla Manuela Crispim
PEREIRA, Jessica Rodrigues
ANDRADE, Larissa Pires de
GARUFFI, Marcelo
AYAN, Carlos
COMINETTI, Marcia Regina
Citação
JOURNAL OF ALZHEIMERS DISEASE, v.43, n.1, p.81-91, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The benefits of physical exercise on improvements in brain-derived neurotrophic factor (BDNF) levels and cognitive functioning have been reported in the literature. However, the variability of individual responses may be linked to genetic differences. BDNF is considered one of the most plausible factors involved in the cognitive benefits associated with physical activity practice. A single nucleotide polymorphism localized in the gene that codes BDNF results in a missense mutation that promotes an amino acid substitution (Val66Met) in the protein. This process has been associated with decreased levels of BDNF secretion, with corresponding impairments in specific cognitive functions. Therefore, the objective of this study was to analyze the effects of a multimodal physical exercise program on peripheral BDNF levels and cognitive functions in elderly individuals with mild cognitive impairment (MCI). The participants were genotyped for the BDNF Val66Met polymorphism. Cognitive functions were assessed by the Montreal Cognitive Assessment (MoCA) prior to and after the intervention. Forty-five participants were assigned to the control and trained groups. The trained group participated in a multimodal physical training for a 16-week period. The results showed a significant between-subjects interaction (p < 0.05), which indicates the beneficial contribution of training on cognitive functions independent of the BDNF genotype. However, only participants with BDNF-Met genotypes exhibited significant improvements in peripheral BDNF levels. The BDNF genotype appears to modulate the effects of physical exercise on BDNF secretion, but it does not influence cognition. This is the first study that evaluated the influence of a BDNF polymorphism on physical activity and cognition performance in elderly MCI individuals.
Palavras-chave
Brain-derived neurotrophic factor, cognition, genetic polymorphism, mild cognitive impairment, physical exercises
Referências
  1. ACSM ACoSM, 2006, AM COLL SPORTS MED G
  2. Almeida OP, 1999, ARQ NEURO-PSIQUIAT, V57, P421, DOI 10.1590/S0004-282X1999000300013
  3. Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8
  4. Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735
  5. Amieva H, 2004, DEMENT GERIATR COGN, V18, P87, DOI 10.1159/000077815
  6. Angevaren M, 2008, COCHRANE DATABASE SY
  7. Barde Y A, 1994, Prog Clin Biol Res, V390, P45
  8. Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050
  9. Buchman AS, 2012, ARCH INTERN MED, V172, P444, DOI 10.1001/archinternmed.2011.1477
  10. Clark BA, 1989, AM J HLTH ED, V60, P66
  11. Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430
  12. Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176
  13. Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4
  14. Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006
  15. Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730
  16. Dias IHK, 2014, J ALZHEIMERS DIS, V40, P399, DOI 10.3233/JAD-131964
  17. Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583
  18. Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
  19. Erickson KI, 2008, FRONT HUM NEUROSCI, V2, P11
  20. Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498
  21. Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054
  22. Erickson KI, 2013, PSYCHOL SCI, V24, P1770, DOI 10.1177/0956797613480367
  23. Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149
  24. Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241
  25. Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007
  26. Hopkins ME, 2012, NEUROSCIENCE, V215, P59
  27. HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
  28. Kim JM, 2011, NEUROBIOL AGING, V32, P551
  29. Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000
  30. Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032
  31. Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009
  32. Kramer AF, 2003, J MOL NEUROSCI, V20, P213, DOI 10.1385/JMN:20:3:213
  33. Lang UE, 2009, MOL PSYCHIATR, V14, P120, DOI 10.1038/mp.2008.80
  34. Larson EB, 2006, ANN INTERN MED, V144, P73
  35. Li R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00039
  36. Lim YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086498
  37. Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603
  38. Memoria CM, 2013, INT J GERIATR PSYCH, V28, P34, DOI 10.1002/gps.3787
  39. Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
  40. Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x
  41. Petersen RC, 2008, CNS SPECTRUMS, V13, P45
  42. Pfeffer RI, 1982, GERONTOLOGY, V37, P323
  43. Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004
  44. Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483
  45. Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8
  46. Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286
  47. Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5
  48. Teixeira CVL, 2012, ARCH GERONTOL GERIAT, V54, P175, DOI 10.1016/j.archger.2011.02.014
  49. Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015
  50. van Uffelen JGZ, 2008, CLIN J SPORT MED, V18, P486, DOI 10.1097/JSM.0b013e3181845f0b
  51. van Uffelen JGZ, 2009, J AGING PHYS ACTIV, V17, P398
  52. Vaughan S, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-60
  53. Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252
  54. VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015
  55. Wang HX, 2013, J GERONTOL A-BIOL, V68, P205, DOI 10.1093/gerona/gls153
  56. Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
  57. Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
  58. Zago AS, 2003, REV BRASILEIRA CIENC, V11, P77
  59. Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533